Literature DB >> 18434934

Clinical and epidemiologic features of Crimean-Congo hemorrhagic fever among children and adolescents from southeastern Iran.

Batool Sharifi-Mood1, Masoud Mardani, Maryam Keshtkar-Jahromi, Mohammad Rahnavardi, Hosein Hatami, Malihe Metanat.   

Abstract

This study aimed to investigate the clinical and epidemiologic features of Crimean-Congo hemorrhagic fever among 34 children and adolescents (mean age, 13.3 +/- 4.6 years) from a highly endemic region. Clinical manifestations were similar to those in adults. The case-fatality ratio was 26.5% (9 of 34). Compared with adult patients, children and adolescents may be more vulnerable to severe and fatal Crimean-Congo hemorrhagic fever.

Entities:  

Mesh:

Year:  2008        PMID: 18434934     DOI: 10.1097/INF.0b013e3181673c28

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  5 in total

Review 1.  Ribavirin for Crimean-Congo hemorrhagic fever: systematic review and meta-analysis.

Authors:  Karla Soares-Weiser; Sherine Thomas; Gail Thomson; Paul Garner
Journal:  BMC Infect Dis       Date:  2010-07-13       Impact factor: 3.090

Review 2.  Ribavirin for treating Crimean Congo haemorrhagic fever.

Authors:  Samuel Johnson; Nicholas Henschke; Nicola Maayan; Inga Mills; Brian S Buckley; Artemisia Kakourou; Rachel Marshall
Journal:  Cochrane Database Syst Rev       Date:  2018-06-05

3.  Investigation of Crimean-Congo hemorrhagic Fever in Patients Admitted in Antani Hospital, Kabul, Afghanistan, 2017-2018.

Authors:  Hossein Hatami; Shohra Qaderi; Ahmad Murad Omid
Journal:  Int J Prev Med       Date:  2019-07-05

4.  Crimean-Congo hemorrhagic fever in children.

Authors:  Hasan Tezer; Iclal Ayranci Sucakli; Tulin Revide Sayli; Elif Celikel; Ibrahim Yakut; Ateş Kara; Bahattin Tunc; Onder Ergonul
Journal:  J Clin Virol       Date:  2010-05-04       Impact factor: 3.168

5.  Prevalence of crimean-congo hemorrhagic Fever among high risk human groups.

Authors:  Batool Sharifi-Mood; Maliheh Metanat; Roya Alavi-Naini
Journal:  Int J High Risk Behav Addict       Date:  2014-03-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.